Google | Web-mail | MyOlemiss
Department of Medicinal Chemistry
University of Mississippi

prasanna
Prasanna Sivaprakasam, M.Pharm.
Ph.D Student, University of Mississippi
B.S., Pharmaceutical Sciences, A. V. P.C., The Tamil Nadu Dr.M.G.R Medical University, Chennai, India
M.Pharm., Medicinal and Pharmaceutical Chemistry, S.G.S.I.T.S, Rajiv Gandhi Proudvogiki Vishwavidvalava, Indore, India
Lab: 662-915-1853
Email : psivapra@olemiss.edu

 

Publications:

•  P. Sivaprakasam, P. Tosso and R. J. Doerksen "Structure-activity relationship and comparative docking studies for cycloguanil analogs as PfDHFR-TS inhibitors" Journal of Chemical Information & Modeling, 49, xxx-yyy (2009).

• S. Prasanna and R. J. Doerksen "Topological Polar Surface Area: A Useful Descriptor in 2D-QSAR," Current Medicinal Chemistry, 16, 21-41 (2009). DOI:10.2174/092986709787002817.

•  A. Xie, S. R. Clark, S. Prasanna and R. J. Doerksen " 3D quantitative structure-farnesyltransferase inhibition analysis for some diaminobenzophenones," Journal of Enzyme Inhibition & Medicinal Chemistry, xx, yyy-zzz (2009).

• S. Prasanna and R. J. Doerksen "Topological Polar Surface Area: A Useful Descriptor in 2D-QSAR," Current Medicinal Chemistry, 16, 21-41 (2009). DOI:10.2174/092986709787002817.

• S. Prasanna, P. R. Daga, A. Xie and R. J. Doerksen "Glycogen synthase kinase-3 inhibition by 3-anilino-4-phenylmaleimides: Insights from 3D-QSAR and docking," Journal of Computer-Aided Molecular Design, 23, yyy-zzz (2009).

• M. A. Ibrahim, A. G. Shilabin, S. Prasanna, M. Jacob, S. I. Khan, R. J. Doerksen and M. T. Hamann "2-N-Methyl Modifications and SAR Studies of Manzamine A," Bioorganic & Medicinal Chemistry, 16, 6702-6706 (2008).

• P. Sivaprakasam, A. Xie and R. J. Doerksen "Probing the physicochemical and structural requirements for glycogen synthase kinase-3alpha inhibition: 2D-QSAR for 3-anilino-4-phenylmaleimides," Bioorganic & Medicinal Chemistry, 14, 8210-8218 (2006).

• A. Xie, P. Sivaprakasam and R. J. Doerksen "3D-QSAR analysis of antimalarial farnesyltransferase inhibitors based on a 2, 5-diaminobenzophenone scaffold," Bioorganic & Medicinal Chemistry, 14, 7311 (2006).